Title
Certolizumab Pegol is Effective for Chronic Plaque Psoriasis Regardless of Previous Exposure to Systemic Therapy: A Pooled Subanalysis of Ongoing Phase 3 Studies (CIMPASI-1, CIMPASI-2, and CIMPACT)
Document Type
Abstract
Publication Date
9-2018
Department
Dermatology
Recommended Citation
Blauvelt, A., Reich, K., Lebwohl, M., Paul, C., Leonardi, C., Thaci, D., Piguet, V., Drew, J., Burge, D., Peterson, L., Rolleri, R., Lacour, J., & Gottlieb, A. B. (2018). Certolizumab Pegol is Effective for Chronic Plaque Psoriasis Regardless of Previous Exposure to Systemic Therapy: A Pooled Subanalysis of Ongoing Phase 3 Studies (CIMPASI-1, CIMPASI-2, and CIMPACT). Journal of the American Academy of Dermatology, 79 (3 Suppl.1), AB66. https://doi.org/10.1016/j.jaad.2018.05.301
COinS
